Granata, Simona
 Distribuzione geografica
Continente #
NA - Nord America 3.053
EU - Europa 2.851
AS - Asia 1.879
SA - Sud America 267
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 35
OC - Oceania 5
Totale 8.230
Nazione #
US - Stati Uniti d'America 2.993
RU - Federazione Russa 1.071
SG - Singapore 676
CN - Cina 583
GB - Regno Unito 569
IT - Italia 344
SE - Svezia 210
BR - Brasile 204
VN - Vietnam 197
FR - Francia 177
HK - Hong Kong 144
IE - Irlanda 137
DE - Germania 124
FI - Finlandia 89
KR - Corea 61
ID - Indonesia 35
BD - Bangladesh 34
IN - India 33
AR - Argentina 28
UA - Ucraina 28
CA - Canada 27
TR - Turchia 27
AT - Austria 19
BE - Belgio 18
JP - Giappone 16
MX - Messico 16
IQ - Iraq 12
ZA - Sudafrica 12
EC - Ecuador 11
PL - Polonia 11
NL - Olanda 9
ES - Italia 8
PK - Pakistan 8
RO - Romania 7
CO - Colombia 6
MY - Malesia 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
UZ - Uzbekistan 5
CL - Cile 4
HN - Honduras 4
IL - Israele 4
MA - Marocco 4
NG - Nigeria 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MT - Malta 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NI - Nicaragua 1
PT - Portogallo 1
Totale 8.090
Città #
Southend 487
Ashburn 375
Singapore 370
Moscow 369
Chandler 360
San Jose 269
Dallas 173
Jacksonville 156
Hong Kong 141
Dublin 133
Beijing 115
Council Bluffs 112
Ann Arbor 108
Woodbridge 96
New York 92
Verona 91
Los Angeles 56
Wilmington 56
Lawrence 50
Princeton 50
The Dalles 50
Houston 45
Dong Ket 40
Jinan 36
Redmond 36
Ho Chi Minh City 35
Buffalo 33
Columbus 32
Santa Clara 32
Hanoi 31
Nanjing 28
Redondo Beach 28
Shenyang 27
São Paulo 24
Seattle 23
Helsinki 22
Hebei 20
Jakarta 20
Tianjin 20
Rome 19
Orem 18
Atlanta 17
Brussels 17
Kent 17
Munich 17
Sindelfingen 17
Tokyo 16
Boardman 15
Ningbo 15
Lancaster 14
Milan 14
Vienna 14
Denver 13
Taizhou 13
Changsha 12
Padova 11
Zhengzhou 11
Brooklyn 10
Guangzhou 10
Jiaxing 10
Phoenix 10
Seoul 10
Ankara 9
Bologna 9
Chicago 9
Nanchang 9
Rio de Janeiro 9
San Francisco 9
Auburn Hills 8
Charlotte 8
Haikou 8
Hangzhou 8
Nuremberg 8
Porto Alegre 8
Quito 8
Redwood City 8
Barnet 7
Biên Hòa 7
Boston 7
London 7
Manchester 7
Montreal 7
Taiyuan 7
Turku 7
Washington 7
Baghdad 6
Chennai 6
Johannesburg 6
Toronto 6
Turin 6
Venice 6
Warsaw 6
Amsterdam 5
Da Nang 5
Frankfurt am Main 5
Fuzhou 5
Haiphong 5
Lanzhou 5
Norwalk 5
Querétaro 5
Totale 4.824
Nome #
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 295
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 261
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 210
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 199
mTOR inhibitors and renal allograft: Yin and Yang. 188
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 188
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 187
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 186
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 185
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 184
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 183
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 183
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 182
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 182
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 179
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 176
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 174
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 173
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 173
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 172
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 170
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 168
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 166
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 163
Dialysis-related systemic microinflammation is associated with specific genomic patterns 161
Mitochondria: a new therapeutic target in chronic kidney disease. 159
mTOR Inhibition Role in Cellular Mechanisms 159
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 159
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 157
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 157
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 154
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 154
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 151
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 150
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 149
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 147
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 145
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 141
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 141
Analysis of urinary exosomes applications for rare kidney disorders. 140
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 134
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 132
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 115
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 107
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 106
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 101
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 85
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 75
Totale 8.230
Categoria #
all - tutte 27.863
article - articoli 25.533
book - libri 0
conference - conferenze 2.330
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.726


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022298 0 0 11 67 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024450 23 39 49 40 57 81 9 40 3 10 82 17
2024/20251.054 52 67 47 202 49 37 68 52 152 50 98 180
2025/20263.348 225 136 173 561 861 247 308 167 177 214 59 220
2026/2027121 47 73 1 0 0 0 0 0 0 0 0 0
Totale 8.230